US Army invests $2million in research to test ‘game changer’ one-shot injection to beat PTSD

Posted 17 Jun, 2017 [ssba]

The US Army has invested $2 million in research to test a promising one-shot injection to treat post-traumatic stress disorder.

The injection – known as stellate ganglion blocks – was invented in 2006, and is used to ‘reset’ the nervous system in soldiers tormented by past trauma.

Now the Pentagon is backing a major study carried out at three Army medical centers to investigate the treatment.

The method is simple: a physician injects a dose of local anesthetic into the right-hand side of the neck, hitting and numbing a cluster of nerves called the stellate ganglion, which connect the body to the brain.

Somehow – for reasons that remain unclear to scientists – this injection seems to reset the nervous system.

Please click the link below to read further:

http://www.dailymail.co.uk/health/article-4597186/US-Army-invests-2million-injection-beat-PTSD.html

 

Have a question? Or would like to book in with us?

Get in Touch

Common Conditions
that we Treat Everyday

View All Conditions

Latest from the Blog

Posted 07 Feb, 2019

Stellate Ganglion Block a Potential Lifesaver in Severe PTSD

Case reports are mounting of immediate, durable, and significant relief of severe refractory symptoms of posttraumatic stress disorder (PTSD), according to an anesthesiologist who has seen the benefits firsthand. Stellate ganglion blockade (SGB) “seems to significantly improve PTSD symptoms as well as significant...
Posted 25 Jan, 2019

CGRP Antagonists: A new era for migraine treatment

Migraine is a common medical condition, affecting as many as 37 million people in the US. It is considered a systemic illness, not just a headache. Recent research has demonstrated that changes may begin to occur in the brain as long as 24 hours before migraine symptoms begin. Many patients have a severe throbbing head...